CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-03 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise | +8,293 | 14,018 | ||
| 2025-01-03 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −3,407 | $14.60 | $50K | 10,611 |
| 2025-01-03 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −8,293 | 24,877 | ||
| 2025-01-03 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise | +7,288 | 10,669 | ||
| 2025-01-03 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Shares withheld for taxes | −2,994 | $14.60 | $44K | 7,675 |
| 2025-01-03 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit | −7,288 | 21,862 | ||
| 2025-01-03 | Faga Daniel President, CEO | Option exercise | +34,678 | 438,036 | ||
| 2025-01-03 | Faga Daniel President, CEO | Shares withheld for taxes | −13,033 | $14.60 | $190K | 425,003 |
| 2025-01-03 | Faga Daniel President, CEO | Option exercise · Restricted Stock Unit | −34,678 | 104,032 | ||
| 2025-01-02 | EcoR1 Capital, LLC Director | Purchase | +6,646 | $12.95 | $86K | 7,880,094 |
| 2024-12-31 | EcoR1 Capital, LLC Director | Purchase | +13,268 | $12.93 | $172K | 7,873,448 |
| 2024-12-30 | EcoR1 Capital, LLC Director | Purchase | +65,184 | $12.92 | $842K | 7,860,180 |
| 2024-11-29 | RENTON HOLLINGS Director | Option exercise 10b5-1 | +10,000 | $6.93 | $69K | 11,950 |
| 2024-11-29 | RENTON HOLLINGS Director | Sale 10b5-1 | −10,000 | $25.00 | $250K | 1,950 |
| 2024-11-29 | RENTON HOLLINGS Director | Option exercise · Common Stock 10b5-1 | −10,000 | 20,925 | ||
| 2024-09-23 | Lizzul Paul F. Chief Medical Officer | Option exercise 10b5-1 | +1,500 | $18.50 | $28K | 16,898 |
| 2024-09-23 | Lizzul Paul F. Chief Medical Officer | Sale 10b5-1 | −1,500 | $38.67 | $58K | 15,398 |
| 2024-09-23 | Lizzul Paul F. Chief Medical Officer | Option exercise · Common 10b5-1 | −1,500 | 85,000 | ||
| 2024-09-17 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale 10b5-1 | −3,780 | $38.41 | $145K | 3,240 |
| 2024-09-16 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale 10b5-1 | −2,220 | $38.93 | $86K | 8,520 |
Page 14 of 17 · 339 trades